Insights Into Chronic Lymphocytic Leukemia (CLL) during the COVID-19 Pandemic—Central

Perspectives of community physicians from the central region of the United States on the management of newly diagnosed and relapsed/refractory chronic lymphocytic leukemia (CLL)

Central – May 20, 2020

Faculty Chair

Nitin Jain, MD

MD Anderson Cancer Center

Example Report

Start discovering the insights

View Report


  • Report providing the insights from a moderated roundtable discussion focusing on treatment of CLL
    Disease state and data presentations were developed in conjunction with Dr Nitin Jain and Dr Roy Chemaly from MD Anderson Cancer Center.
  • Insights on the following topics will be obtained:
    • Cancer Care During the COVID-19 Pandemic
    • Treatment of Relapsed/Refractory CLL
  • Data collection was accomplished through use of audience response system questioning and in-depth moderated discussion


  • The group of advisors comprised community oncologists from the central region of the United States

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.